Enokizumab

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEnokizumab
Drug Alias Nameenokizumabum依诺凯珠单抗Anti-IL-9 monoclonal antibody依诺吉珠单抗Anti-interleukin-9 monoclonal antibody +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionInterleukin-9 inhibitors
TargetsInterleukin-9
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaPanamaUnited States +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenaeraLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG